Optimized antibodies that target HM1.24

Details for Australian Patent Application No. 2007299843 (hide)

Owner Xencor, Inc

Inventors Muchhal, Umesh S.; Lazar, Gregory Alan; Bernett, Matthew J.; Nguyen, Duc-Hanh Thi; Desjarlais, John R.; Karki, Sher Bahadur; Richards, John O.

Agent Davies Collison Cave

Pub. Number AU-B-2007299843

PCT Pub. Number WO2008/036688

Priority 60/885,848 19.01.07 US; 60/826,054 18.09.06 US

Filing date 18 September 2007

Wipo publication date 27 March 2008

Acceptance publication date 8 March 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/036688 Priority application(s): WO2008/036688

8 March 2012 Application Accepted

  Published as AU-B-2007299843

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007299846-Biomarkers for prostate cancer and methods using the same

2007299828-MicroRNAs differentially expressed in pancreatic diseases and uses thereof